- Home
- IDYA vs CLSK Comparison
IDYA vs CLSK Comparison
Compare IDYA & CLSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- CLSK
- Stock Information
- Founded
- IDYA 2015
- CLSK 1987
- Country
- IDYA United States
- CLSK United States
- Employees
- IDYA N/A
- CLSK N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- CLSK Finance: Consumer Services
- Sector
- IDYA Health Care
- CLSK Finance
- Exchange
- IDYA Nasdaq
- CLSK Nasdaq
- Market Cap
- IDYA 2.6B
- CLSK 3.0B
- IPO Year
- IDYA 2019
- CLSK N/A
- Fundamental
- Price
- IDYA $26.64
- CLSK $14.03
- Analyst Decision
- IDYA Strong Buy
- CLSK Strong Buy
- Analyst Count
- IDYA 12
- CLSK 7
- Target Price
- IDYA $53.08
- CLSK $21.21
- AVG Volume (30 Days)
- IDYA 750.9K
- CLSK 35.9M
- Earning Date
- IDYA 11-04-2024
- CLSK 11-29-2024
- Dividend Yield
- IDYA N/A
- CLSK N/A
- EPS Growth
- IDYA N/A
- CLSK N/A
- EPS
- IDYA N/A
- CLSK N/A
- Revenue
- IDYA $3,922,000.00
- CLSK $342,213,000.00
- Revenue This Year
- IDYA N/A
- CLSK $140.64
- Revenue Next Year
- IDYA $158.10
- CLSK $96.42
- P/E Ratio
- IDYA N/A
- CLSK N/A
- Revenue Growth
- IDYA N/A
- CLSK 140.89
- 52 Week Low
- IDYA $26.41
- CLSK $3.75
- 52 Week High
- IDYA $47.74
- CLSK $24.72
- Technical
- Relative Strength Index (RSI)
- IDYA 33.96
- CLSK 55.99
- Support Level
- IDYA $27.52
- CLSK $9.70
- Resistance Level
- IDYA $32.67
- CLSK $17.97
- Average True Range (ATR)
- IDYA 1.44
- CLSK 1.39
- MACD
- IDYA -0.04
- CLSK 0.21
- Stochastic Oscillator
- IDYA 3.75
- CLSK 52.36
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About CLSK CleanSpark Inc.
Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.